Subsequent studies have shown that in this type of carcinoma, NTRK rearrangements take place in the tyrosine kinase domain of the NTRK1 gene and the 5 ′end of the 3 partners (TRKT1, TRKT2 and TRKT3). Here, NTRK1 is linked to carcinoma.